DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Faculty of Arts and Sciences
  3. FAS Theses and Dissertations
  4. IL-27-driven immunoregulatory pathways in T cells

IL-27-driven immunoregulatory pathways in T cells

Open/View files
20211109_Thesis_Huiyuan Zhang.pdf (5.91 MB)
Date
March 17, 2022
Author(s)
Zhang, Huiyuan
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Zhang, Huiyuan. 2021. IL-27-driven immunoregulatory pathways in T cells. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.
Abstract
IL-27 is a pleiotropic cytokine that exert immunoregulatory functions through multiple mechanisms, including induction of IL-10 and multiple co-inhibitory receptors on T cells, but the transcriptional network mediating its diverse functions remains unclear. Combining high-resolution temporal RNA profiling with computational algorithms, we predicted 79 transcription factors induced by IL-27 in T cells. We genetically perturbed 24 TFs and generated an experimentally refined regulatory network for Il10. Our study validated 11 known and discovered 5 positive (Cebpb, Fosl2, Tbx21, Hlx, Atf3) and 2 negative (Irf9, Irf8) Il10 regulators. We report two central regulators, Prdm1 and Maf, that cooperatively drive the expression of signature genes induced by IL-27 in Type 1 regulatory T cells, mediate IL-10 expression in other helper T cells and determine the regulatory phenotype of colonic Foxp3+ regulatory T cells. Prdm1/Maf double-knockout mice develop spontaneous colitis, phenocopying the Il10-deficient mice. Our work provides insights into IL-27 driven transcriptional networks and identifies two shared Il10 regulators that orchestrate immunoregulatory programs across T helper cell subsets. In addition, using the IL-27-induced co-inhibitory gene module as a tool, we discovered LILRB4 as a new co-inhibitory receptor for cancer immunotherapy. Lilrb4-deficient mice are better at controlling tumor growth with improved effector T cell functions in the tumor microenvironment. Transferring Lilrb4-deficient Tregs partially recapitulates the tumor growth control observed in Lilrb4-deficient mice, indicating a Treg-cell intrinsic role of LILRB4 in regulating tumor growth. Moreover, we showed that LILRB4 is preferentially expressed by pathogenic Th17 cells compared to non-pathogenic homeostatic Th17 cells. LILRB4 restrains the encephalitogenicity of Th17 cells in experimental autoimmune encephalomyelitis. Our work demonstrates LILRB4 as a co-inhibitory receptor on T cell that has important function in both cancer and autoimmunity. In summary, our studies provide insights on how IL-27 suppresses autoimmunity and anti-tumor immunity by regulating IL-10 production and expression of known and novel co-inhibitory molecules such as LILRB4 in T cells.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37371124
Subjects

Immunology

Collection
FAS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.